Viewing nowCombinationDouble Star Tablet 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
TDS Pharm Co., Ltd.

MFDS item code 201900624 · Approved 2019.01.24 · Insurance code 679801770
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension refers to a continuously high blood pressure condition, and this medication is used when blood pressure is not sufficiently controlled with either telmisartan or amlodipine monotherapy. These medications help lower blood pressure and reduce the risk of cardiovascular disease. This can effectively prevent complications from hypertension and maintain health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section '3. Patients requiring caution in administration'.) In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Children: Administration of this medicine is not recommended for children 18 years of age or younger because its safety and efficacy have not been established.
This medication can cause serious damage to the fetus if taken during pregnancy, especially in the second and third trimesters, thus it should not be taken by pregnant women or women who may become pregnant. This medication should not be given to patients who are allergic to the active substance or similiar substances, pregnant women, nursing mothers, patients with severely impaired liver function, and those with serious heart or blood pressure issues. Patients with weakened liver function, gastrointestinal conditions, kidney problems, and the elderly should be particularly cautious when using this medication and must follow a doctor's instructions. Taking this medication may cause side effects such as dizziness or swelling, so if symptoms are severe or persistent, immediate consultation with medical personnel is required. This medication has blood pressure-lowering effects, which may lead to symptoms of hypotension, particularly in dehydrated patients or those taking diuretics. There is a risk of increased potassium levels in the blood, so if taking potassium-rich medications or supplements, it should be done under a doctor's guidance. Patients with impaired kidney function should have their kidney function and electrolyte levels regularly checked before and after taking this medication. This medication may interact with other blood pressure medications or certain drugs, so if other medications are being taken, it is essential to inform medical personnel. Dizziness or drowsiness may occur while driving or operating machinery, so caution is advised. This medication contains sorbitol, so patients with fructose intolerance should not take it. In case of overdose, serious symptoms such as hypotension, dizziness, and heart rate changes may occur, requiring immediate visit to a medical institution; treatment will be based on symptoms. This medication is not recommended for use in children as its safety and efficacy have not been established.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container that can block light and air, and it is recommended to keep it at room temperature between 1°C and 30°C. This storage will help maintain the medication's effectiveness and prevent deterioration.
Biconvex oval double tablet with white and light blue coloring
30 tablets (10 tablets/PTP×3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
TDS Pharm Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.